Experts Voice Concerns Over Unapproved Treatments and Public Health Gaps

Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy, warned that the public should not be exposed to unproven remedies, reacting to the FDA’s warning to Amazon about unauthorized herpes treatments.

Jeanne Marrazzo, MD, MPH, former director of the National Institute of Allergy and Infectious Diseases, described the federal response to the recent U.S. measles outbreak as underwhelming and shameful.

Jennifer Mensik Kennedy, RN, PhD, president of the American Nurses Association, noted that with 18 nurses seeking congressional seats, the legislature would benefit from greater representation of nursing professionals.

Sanjay Saint, MD, of Northwell Health in Lake Success, New York, observed that hospitals are increasingly prioritizing the avoidance of unnecessary catheter use and shortening catheter duration to improve patient safety and curb catheter‑associated urinary tract infections.

Brian Jenssen, MD, MSHP, from Children’s Hospital of Philadelphia, emphasized that when assessing smoking exposure in the home, clinicians must also inquire about vaping, especially for children with asthma who may encounter both combustible tobacco and electronic nicotine products.

Joshua Lieberman, MD, PhD, of the University of Washington School of Medicine in Seattle, expressed concern that a rare but lethal fungal infection is appearing outside the usual high‑risk, immunocompromised groups.

Mohamed Khattab, MD, of the University of South Florida in Tampa, suggested that radiosurgical capsulotomy could be a life‑saving option for patients with treatment‑resistant depression and suicidal ideation, based on promising early results.

Richard Rosen, MD, of the Icahn School of Medicine at Mount Sinai in New York City, said that current therapies offer little hope for patients with advanced retinitis pigmentosa, underscoring the need for new approaches such as optogenetic strategies to restore light sensitivity in retinal ganglion cells.

Source link